Stem Cell Treatment for Lyme Disease
- Home >
- Services >
- Stem Cell Treatment for Lyme Disease
Chronic Lyme Disease
Research Supporting Stem Cell Treatment for Lyme Disease—What the Science Says
Lyme disease affects millions across the United States, and for many, conventional antibiotic treatment is not enough. At STG Stem Cells, our regenerative protocols are grounded in an expanding body of stem cell research that supports the use of MSC-based therapies for chronic Lyme disease and Post-Treatment Lyme Disease Syndrome (PTLDS)
476,000
Americans diagnosed with Lyme annually (CDC)
10%
Patients develop PTLDS after treatment
4
Clinical-grade biologics available
Understanding Chronic Lyme Disease & Why Conventional Treatment Falls Short
Lyme disease is caused by the spirochete bacterium Borrelia burgdorferi—one of the most prevalent vector-borne diseases in the United States. While early antibiotic treatment is typically effective, a significant subset of patients continues to experience debilitating symptoms long after treatment ends.
“10–15% of ideally treated Lyme disease patients develop Post-Treatment Lyme Disease Syndrome (PTLDS), characterized by persistent or recurrent symptoms of fatigue, musculoskeletal pain, and cognitive complaints leading to functional decline.” (Marques, A. — Infectious Disease Society of America / ScienceDirect, 2013)
This is precisely the patient population for whom STG Stem Cells has developed its stem cell therapy for chronic Lyme disease programs—targeting the underlying immune dysregulation and systemic inflammation that antibiotics cannot resolve.
The Stem Cell Research Foundation—Why MSCs Work for Lyme Disease
Stem cell research consistently identifies mesenchymal stem cells (MSCs) as uniquely suited to addressing the core mechanisms driving chronic Lyme disease. Three biological properties make them especially relevant:
Core MSC Properties Relevant to Lyme Disease
Anti-Inflammatory Action
MSCs suppress overactive immune responses and modulate cytokine storms—the primary driver of persistent Lyme symptoms
Immunomodulation
MSCs regulate dysregulated immune function without compromising the body's natural defenses, addressing the immune dysfunction that underlies PTLDS
Tissue Repair
MSCs promote repair of damaged neurons, connective tissues, and musculoskeletal structures—directly targeting the physical damage caused by chronic Lyme infection
“Human mesenchymal stem cells (MSCs) are of growing clinical interest due to their immunomodulatory properties, low immunogenicity, and potential to promote tissue repair—positioning MSCs as promising adjuvant therapies for chronic Lyme disease.” (Rowan University Stem Cell Research Program, 2025)
Key Stem Cell Research & Therapy Findings — Lyme Disease Evidence
The field of stem cell research & therapy has produced a growing number of case studies and clinical findings that directly support the use of stem cell treatment for Lyme disease. Here is what the research shows:
Landmark Study—Human Embryonic Stem Cells & Lyme Disease
“This is the first known case report in the medical literature describing improvement of both Lyme disease and CVID with human embryonic stem cell therapy.” (Soni et al., Journal of Medical Case Reports / PMC, 2018)
This landmark finding marked a pivotal moment in stem cell research for Lyme disease—demonstrating that stem cell intervention could produce measurable clinical improvement in patients with complex, treatment-resistant Lyme presentations.
Animal Model Evidence—MSCs Reduce Lyme Arthritis Inflammation
“Low and high hUC-MSC doses significantly reduced bilateral hind limb swelling in Lyme arthritis mice—demonstrating direct anti-inflammatory effects of MSC therapy against Borrelia burgdorferi-driven inflammation.” (Ma et al., Stem Cells International / PubMed, 2025)
This preclinical evidence reinforces the mechanistic basis for stem cell therapy for chronic Lyme disease—confirming that MSCs can actively reduce the localized and systemic inflammation central to Lyme arthritis and PTLDS.
Case Series—MS and Lyme Disease Patient Outcomes
“Stem cells stimulated functional restoration by rebuilding neural circuits, remyelinating axons, and increasing plasticity or axon regeneration—with the immunoregulatory properties of MSCs efficiently intervening with the autoimmune attack.” (PMC, 2016—Transplantation of Human Embryonic Stem Cells in MS and Lyme Disease)
Stem Cell Research vs. Conventional Antibiotic Treatment—A Clinical Perspective
The STG Stem Cells Approach to Stem Cell Therapy for Chronic Lyme Disease
At STG Stem Cells, stem cell research and therapy are not an abstract concept — it is the direct clinical foundation of every treatment protocol. Every patient presenting with chronic Lyme disease or PTLDS receives a fully individualized program built on the four regenerative products proven most effective for their symptom profile.s]
“Early evidence and mechanistic rationale suggest that MSC-based therapies may mitigate the physiological consequences of persistent Lyme disease.” (Rowan University Stem Cell Research Program, 2025)
The STG Stem Cells medical team evaluates each patient’s condition—including the severity of PTLDS symptoms, neurological involvement, joint damage, and fatigue—before recommending the specific product, dosage, and administration route best suited to their needs.
Stem Cell Research Program at STG Stem Cells—How We Stay Ahead
STG Stem Cells is committed to remaining aligned with the latest advances in stem cell research & therapy. Our stem cell research program reflects a dedication to clinically validated, evidence-informed protocols—ensuring every patient receives regenerative care that reflects current science, not outdated treatment models.
What Sets the STG Stem Cells Research-Backed Approach Apart
- Protocols grounded in peer-reviewed stem cell research for Lyme disease—not experimental claims
- Four distinct regenerative products were selected based on their individual clinical evidence profiles
- Administration routes matched to the patient's specific symptom presentation and therapeutic goals
- Fully personalized protocols designed by a dedicated medical team with specialist regenerative medicine expertise
Frequently Asked Questions About Stem Cell Research & Lyme Disease
This content is for informational purposes only and does not constitute medical advice. This product is not intended to diagnose, treat, cure, or prevent any disease or condition.
Quick Navigation
Our Products
Advance Your Practice with Regenerative Biologics
Ready to Start Your Healing Journey?
Your path to healing starts with one conversation. Let STG Stem Cells help you take that first step—with a free, no-obligation consultation with our medical team.